zimberelimab,toripalimab,tislelizumab,cisplatin,sintilimab,penpulimab,paclitaxel,camrelizumab
sino biopharmaceuticals,beigene,otsuka,eli lilly,arcus biosciences,Coherus,junshi biosciences,gilead sciences,jiangsu hengrui pharmaceuticals,akesobio,innovent biologics
['nsclc', 'sclc', 'ca,022,i', 'zimberelimab', 'ca,022,1', ' cam ', 'cisplatin', 'paclitaxel', 'toripalimab', 'ca,022,001', 'carboplatin', 'tislelizumab', 'esophageal', 'nedaplatin', 'gloria', 'sintilimab', 'albumin,bound,paclitaxel', 'penpulimab', 'camrelizumab', 'innovent', ' lilly', 'coherus', 'eli lilly', 'beigene', 'biotec,(-biotech)']
camrelizumab .this is the sixth home grown anti pdl1 drug in china. approved &amp; sold in china for 8 different cancers . can home grown chinese io drugs be an alternative for western io drugs ? cost effective io ? 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists